共 50 条
- [1] Neuropathy impairment and nutritional status with eplontersen in patients with hereditary transthyretin-mediated amyloidosis AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2024, 31 : S68 - S68
- [2] Hope on the horizon: FDA approves eplontersen for hereditary transthyretin-mediated amyloidosis ANNALS OF MEDICINE AND SURGERY, 2025, 87 (01): : 20 - 23
- [5] Patisiran in hereditary transthyretin-mediated amyloidosis LANCET NEUROLOGY, 2021, 20 (01): : 21 - 23
- [6] Effects of eplontersen on symptoms of autonomic neuropathy in hereditary transthyretin-mediated amyloidosis: secondary analysis from the NEURO-TTRansform trial AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2025, 32 (01): : 29 - 38